Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients.

Aguiar MF, Faria-Janes AL, Garcia-Brandes GI, Takemi-Emori C, Ferraz MLG, Andrade LEC, de Souza AWS.

Ann Hepatol. 2019 May 21. pii: S1665-2681(19)30337-0. doi: 10.1016/j.aohep.2019.04.010. [Epub ahead of print]

2.

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.

Benzaken AS, Girade R, Catapan E, Pereira GFM, Almeida EC, Vivaldini S, Fernandes N, Razavi H, Schmelzer J, Ferraz ML, Ferreira PRA, Pessoa MG, Martinelli A, Souto FJD, Walsh N, Correa MCM.

Braz J Infect Dis. 2019 May 27. pii: S1413-8670(19)30127-8. doi: 10.1016/j.bjid.2019.04.010. [Epub ahead of print]

3.

Changing pattern of chronic hepatitis C in renal transplant patients over 20 years.

Emori CT, Uehara SNO, Carvalho-Filho RJ, Amaral AC, Silva ISSE, Lanzoni VP, Moreira SR, Silva-Souza AL, Gama RA, Nunes EJS, Leopércio APS, Appel F, Silva AEB, Medina-Pestana JO, Ferraz MLG.

Eur J Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1097/MEG.0000000000001404. [Epub ahead of print]

PMID:
30964809
4.

How are HCV-infected patients being identified in Brazil: a multicenter study.

Portari-Filho LH, Álvares-da-Silva MR, Gonzalez A, Ferreira AP, Nogueira CV, Mendes-Correa MC, Lima JM, Lopes EP, Brandão CE, Ivantes C, Lyra A, Lindenberg A, Ferraz ML.

Braz J Infect Dis. 2019 Jan - Feb;23(1):34-39. doi: 10.1016/j.bjid.2019.01.006. Epub 2019 Mar 6.

5.

Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach.

Constancio NS, Ferraz MLG, Martins CTB, Kraychete AC, Bitencourt PL, Nascimento MMD.

J Bras Nefrol. 2019 Feb 18. pii: S0101-28002019005007101. doi: 10.1590/2175-8239-JBN-2018-0177. [Epub ahead of print] English, Portuguese.

6.

Analysis of the electromiographic activity of lower limb and motor function in hippotherapy practitioners with cerebral palsy.

Ribeiro MF, Espindula AP, Lage JB, Bevilacqua Júnior DE, Diniz LH, Mello EC, Ferreira AA, Ferraz MLF, Teixeira VPA.

J Bodyw Mov Ther. 2019 Jan;23(1):39-47. doi: 10.1016/j.jbmt.2017.12.007. Epub 2017 Dec 9.

PMID:
30691759
7.

Width of sulcus and thickness of gyrus in patients with cerebral atherosclerosis: a new tool for the prevention of vascular cognitive impairment.

Ramalho LS, Silveira LAMD, Fonseca BC, Félix JER, Morais LJ, Soares MH, Ferraz MLF, Teixeira VPA, Pereira SAL.

Rev Assoc Med Bras (1992). 2018 Aug;64(8):684-691. doi: 10.1590/1806-9282.64.08.684.

8.

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.

Pessoa MG, Ramalho-Madruga JV, Alves K, Nunes EP, Cheinquer H, Brandão-Mello CE, Mendes-Correa MC, Ferraz ML, Ferreira PRA, Álvares-da-Silva MR, Coelho HS, Affonso-de-Araújo ES, Furtado J, Parana R, Silva G, Lari SA, Liu L, Tripathi R, Pilot-Matias T, Cohen DE, Shulman NS, Martinelli A.

Ann Hepatol. 2018 Oct 16;17(6):959-968. doi: 10.5604/01.3001.0012.7196.

9.

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus.

Tavares RCF, de Castro Amaral Feldner AC, Pinho JRR, de Mello Malta F, Carvalho-Filho RJ, Santana RAF, de Castro VFD, Dastoli GTF, Lima JC, Ferraz MLCG.

Infect Drug Resist. 2018 Oct 25;11:1993-2000. doi: 10.2147/IDR.S169512. eCollection 2018. Erratum in: Infect Drug Resist. 2018 Dec 24;12:65.

10.

Genomic and epidemiological monitoring of yellow fever virus transmission potential.

Faria NR, Kraemer MUG, Hill SC, Goes de Jesus J, Aguiar RS, Iani FCM, Xavier J, Quick J, du Plessis L, Dellicour S, Thézé J, Carvalho RDO, Baele G, Wu CH, Silveira PP, Arruda MB, Pereira MA, Pereira GC, Lourenço J, Obolski U, Abade L, Vasylyeva TI, Giovanetti M, Yi D, Weiss DJ, Wint GRW, Shearer FM, Funk S, Nikolay B, Fonseca V, Adelino TER, Oliveira MAA, Silva MVF, Sacchetto L, Figueiredo PO, Rezende IM, Mello EM, Said RFC, Santos DA, Ferraz ML, Brito MG, Santana LF, Menezes MT, Brindeiro RM, Tanuri A, Dos Santos FCP, Cunha MS, Nogueira JS, Rocco IM, da Costa AC, Komninakis SCV, Azevedo V, Chieppe AO, Araujo ESM, Mendonça MCL, Dos Santos CC, Dos Santos CD, Mares-Guia AM, Nogueira RMR, Sequeira PC, Abreu RG, Garcia MHO, Abreu AL, Okumoto O, Kroon EG, de Albuquerque CFC, Lewandowski K, Pullan ST, Carroll M, de Oliveira T, Sabino EC, Souza RP, Suchard MA, Lemey P, Trindade GS, Drumond BP, Filippis AMB, Loman NJ, Cauchemez S, Alcantara LCJ, Pybus OG.

Science. 2018 Aug 31;361(6405):894-899. doi: 10.1126/science.aat7115. Epub 2018 Aug 23.

PMID:
30139911
11.

Prevalence of hepatitis delta virus among hemodialysis and renal transplant patients.

Pierre AMMA, Feldner ACCA, Carvalho Filho RJ, Lopes EPA, Gouvea MSG, Pinho JRR, Carvente CT, Emori CT, Silva GAD, Ferraz MLCG.

Int J Artif Organs. 2018 Mar;41(3):171-174. doi: 10.1177/0391398817752989.

PMID:
29546807
12.

[American tegumentary leishmaniasis: a multivariate analysis of the spatial circuits for production of cases in Minas Gerais State, Brazil, 2007 to 2011].

Temponi AOD, Brito MG, Ferraz ML, Diniz SA, Silva MX, Cunha TND.

Cad Saude Publica. 2018 Feb 19;34(2):e00165716. doi: 10.1590/0102-311X00165716. Portuguese. Erratum in: Cad Saude Publica. 2018 Jun 21;34(6):eER165716.

13.

Rupture of the myocardium in autopsied MI hearts.

Monteiro VB, Torquato BGS, Juliano GR, Fonseca BCD, Oliveira FA, Cunha DFD, Cavellani CL, Silveira LAMD, Ferraz MLDF, Teixeira VPA, Fernandes EL.

Rev Assoc Med Bras (1992). 2017 Sep;63(9):733-735. doi: 10.1590/1806-9282.63.09.733.

14.

Tongue development in stillborns autopsied at different gestational ages.

Aguiar LS, Juliano GR, Silveira LAM, Oliveira MS, Torquato BGS, Juliano GR, Araújo MF, Pereira SAL, Teixeira VPA, Ferraz MLF.

J Pediatr (Rio J). 2018 Nov - Dec;94(6):616-623. doi: 10.1016/j.jped.2017.08.009. Epub 2017 Nov 4.

15.

Molecular characterization of hepatitis C virus in end-stage renal disease patients under hemodialysis.

Alves da Silva R, de Souza Todão J, Kamitani FL, Silva AEB, de Carvalho-Filho RJ, Ferraz MLCG, de Carvalho IMVG.

J Med Virol. 2018 Mar;90(3):537-544. doi: 10.1002/jmv.24976. Epub 2017 Nov 16.

PMID:
29064576
16.

Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold Standard.

Fernandes FF, Perazzo H, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Ferraz ML, Perez RM.

Biomed Res Int. 2017;2017:8252980. doi: 10.1155/2017/8252980. Epub 2017 Sep 13.

17.

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.

Callefi LA, Villela-Nogueira CA, de Barros Tenore S, Carnaúba-Júnior D, Coelho HSM, Pinto PTA, Nabuco LC, Pessoa MG, Ferraz MLCG, Ferreira PRA, de Lourdes Candolo Martinelli A, Chachá SGF, de Souza Paiva Ferreira A, de Macedo Bisio AP, Brandão-Mello CE, Álvares-Da-Silva MR, Reuter T, Ivantes CAP, de Mello Perez R, Mendes-Correa MCJ.

Clinics (Sao Paulo). 2017 Jun;72(6):378-385. doi: 10.6061/clinics/2017(06)08.

18.

Implications of alcoholic cirrhosis in atherosclerosis of autopsied patients.

Silveira LAMD, Torquato BGS, Oliveira MS, Juliano GR, Oliveira LF, Cavellani CL, Ramalho LS, Espindula AP, Teixeira VPA, Ferraz MLF.

Rev Assoc Med Bras (1992). 2017 Apr;63(4):336-340. doi: 10.1590/1806-9282.63.04.336.

19.

Expansion and intensification of humoral autoimmune response in the transition from preclinical to full-blown primary biliary cholangitis.

Dellavance A, Ferraz MLG, Cançado ELR, Andrade LEC.

Hepatology. 2017 Sep;66(3):997. doi: 10.1002/hep.29260. Epub 2017 Jul 27. No abstract available.

PMID:
28510307
20.

Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.

Tavares RCF, Feldner ACCA, Pinho JRR, Uehara SNO, Emori CT, Carvalho-Filho RJ, Silva ISS, Santana RAF, de Castro VFD, Castoli GTF, Cristovão CU, Ferraz MLCG.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):754-758. doi: 10.1097/MEG.0000000000000866.

PMID:
28234637
21.

Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodies.

Keppeke GD, Prado MS, Nunes E, Perazzio SF, Rodrigues SH, Ferraz ML, Chan EK, Andrade LE.

Clin Immunol. 2016 Dec;173:149-156. doi: 10.1016/j.clim.2016.10.004. Epub 2016 Oct 13.

PMID:
27746381
22.

The γ-glutamyl transpeptidase to platelet ratio (GPR) in HBV patients: just adding up?

Schiavon LL, Narciso-Schiavon JL, Ferraz MLG, Silva AEB, Carvalho-Filho RJ.

Gut. 2017 Jun;66(6):1169-1170. doi: 10.1136/gutjnl-2016-312658. Epub 2016 Aug 17. No abstract available.

PMID:
27534672
23.

Enhanced liver fibrosis (ELF) score: Analytical performance and distribution range in a large cohort of blood donors.

Dellavance A, Fernandes F, Shimabokuro N, Latini F, Baldo D, Barreto JA, Marvulle V, Andrade LE, Ferraz ML.

Clin Chim Acta. 2016 Oct 1;461:151-5. doi: 10.1016/j.cca.2016.08.006. Epub 2016 Aug 9.

PMID:
27520747
24.

Hepatitis E virus seroprevalence among schistosomiasis patients in Northeastern Brazil.

Passos-Castilho AM, de Sena A, Domingues AL, Lopes-Neto EP, Medeiros TB, Granato CF, Ferraz ML.

Braz J Infect Dis. 2016 May-Jun;20(3):262-6. doi: 10.1016/j.bjid.2016.03.001. Epub 2016 Mar 26.

25.

High incidence of tuberculosis in patients treated for hepatitis C chronic infection.

de Oliveira Uehara SN, Emori CT, Perez RM, Mendes-Correa MC, de Souza Paiva Ferreira A, de Castro Amaral Feldner AC, Silva AE, Filho RJ, de Souza E Silva IS, Ferraz ML.

Braz J Infect Dis. 2016 Mar-Apr;20(2):205-9. doi: 10.1016/j.bjid.2015.12.003. Epub 2016 Feb 9.

26.

The Infertility of Repeat-Breeder Cows During Summer Is Associated with Decreased Mitochondrial DNA and Increased Expression of Mitochondrial and Apoptotic Genes in Oocytes.

Ferreira RM, Chiaratti MR, Macabelli CH, Rodrigues CA, Ferraz ML, Watanabe YF, Smith LC, Meirelles FV, Baruselli PS.

Biol Reprod. 2016 Mar;94(3):66. doi: 10.1095/biolreprod.115.133017. Epub 2016 Feb 3.

PMID:
26843447
27.

ASSOCIATION OF THE NUTRITIONAL PROFILE WITH HISTOLOGICAL FINDINGS OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION.

Silva VA, Ferraz ML, Carvalho-Filho Rd, Lanzoni VP, Silva AE, Silva IS.

Arq Gastroenterol. 2015 Dec;52(4):315-20. doi: 10.1590/S0004-28032015000400012.

28.

Influence of AIDS in collagen deposition and thickness of the bone marrow.

Dias NF, Juliano GR, Espindula AP, de Oliveira FA, Oliveira LF, Cavellani CL, Ramalho LS, Teixeira Vde P, Ferraz ML.

Ann Diagn Pathol. 2015 Dec;19(6):409-13. doi: 10.1016/j.anndiagpath.2015.10.003. Epub 2015 Oct 20.

29.

Clinical and epidemiological profile of female blood donors with positive serology for viral hepatitis B.

Narciso-Schiavon JL, Schiavon Lde L, Carvalho-Filho RJ, Emori CT, Maryia FA, Bordin JO, Silva AE, Ferraz ML.

Rev Soc Bras Med Trop. 2015 Sep-Oct;48(5):524-31. doi: 10.1590/0037-8682-0157-2015.

30.

Variability of susceptibility to deltamethrin in peridomestic Triatoma sordida from Triângulo Mineiro, State of Minas Gerais, Brazil.

Pessoa GC, dos Santos TR, Salazar GC, Dias LS, de Mello BV, Ferraz ML, Diotaiuti L.

Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):417-21. doi: 10.1590/0037-8682-0047-2015.

31.

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.

Shiffman ML, Cheinquer H, Berg CP, Berg T, de Figueiredo-Mendes C, Dore GJ, Ferraz ML, Mendes-Corrêa MC, Lima MP, Parise ER, Rios AM, Reuter T, Sanyal AJ, Shafran SD, Hohmann M, Tatsch F, Bakalos G, Zeuzem S.

Hepatol Int. 2014 Oct;8(4):517-26. doi: 10.1007/s12072-014-9555-3. Epub 2014 Jul 24.

PMID:
26202757
32.

Disease burden of chronic hepatitis C in Brazil.

Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC.

Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4.

33.

Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection.

Wahle RC, Perez RM, Pereira PF, Oliveira EM, Emori CT, Uehara SN, Silva IS, Silva AE, Ferraz ML.

Braz J Infect Dis. 2015 Sep-Oct;19(5):533-7. doi: 10.1016/j.bjid.2015.04.003. Epub 2015 May 18.

34.

Deltamethrin toxicological profile of peridomestic Triatoma sordida in the North of Minas Gerais, Brazil.

Pessoa GC, Obara MT, Rezende JG, de Mello BV, Ferraz ML, Diotaiuti L.

Parasit Vectors. 2015 May 8;8:263. doi: 10.1186/s13071-015-0873-7.

35.

Standardization of laboratory bioassays for the study of Triatoma sordida susceptibility to pyrethroid insecticides.

Pessoa GC, Pinheiro LC, Ferraz ML, de Mello BV, Diotaiuti L.

Parasit Vectors. 2015 Feb 19;8:109. doi: 10.1186/s13071-015-0726-4.

36.

Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.

Passos-Castilho AM, Lo Turco E, Ferraz ML, Matos C, Silva I, Parise E, Pilau E, Gozzo F, Granato C.

J Gastrointestin Liver Dis. 2015 Mar;24(1):43-9. doi: 10.15403/jgld.2014.1121.pas.

37.

ELF cut-off points: aetiology is also a relevant factor.

Fernandes FF, Perez RM, Ferraz ML.

Liver Int. 2015 Jul;35(7):1920-1. doi: 10.1111/liv.12815. Epub 2015 Mar 15. No abstract available.

PMID:
25728548
38.

Paradoxical effects of bovine somatotropin treatment on the ovarian follicular population and in vitro embryo production of lactating buffalo donors submitted to ovum pick-up.

Ferraz ML, Sá Filho MF, Batista EO, Watanabe YF, Watanabe MR, Dayan A, Joaquim DC, Accorsi MR, Gimenes LU, Vieira LM, Baruselli PS.

Anim Reprod Sci. 2015 Mar;154:1-7. doi: 10.1016/j.anireprosci.2014.12.017. Epub 2015 Jan 8.

PMID:
25623138
39.

Management of hepatitis C in patients with chronic kidney disease.

Carvalho-Filho RJ, Feldner AC, Silva AE, Ferraz ML.

World J Gastroenterol. 2015 Jan 14;21(2):408-22. doi: 10.3748/wjg.v21.i2.408. Review.

40.

The interval between the emergence of pharmacologically synchronized ovarian follicular waves and ovum pickup does not significantly affect in vitro embryo production in Bos indicus, Bos taurus, and Bubalus bubalis.

Gimenes LU, Ferraz ML, Fantinato-Neto P, Chiaratti MR, Mesquita LG, Sá Filho MF, Meirelles FV, Trinca LA, Rennó FP, Watanabe YF, Baruselli PS.

Theriogenology. 2015 Feb;83(3):385-93. doi: 10.1016/j.theriogenology.2014.09.030. Epub 2014 Oct 13.

PMID:
25447149
41.

Dengue virus serotype 4 in a highly susceptible population in Southeast Brazil.

Amâncio FF, Ferraz ML, Almeida MC, Pessanha JE, Iani FC, Fraga GL, Lambertucci JR, Carneiro M.

J Infect Public Health. 2014 Nov-Dec;7(6):547-52. doi: 10.1016/j.jiph.2014.07.016. Epub 2014 Aug 30.

42.

Acute exacerbation of chronic hepatitis B virus infection in renal transplant patients.

Emori CT, Perez RM, Matos CA, Uehara SN, Pereira Pda S, Feldner AC, Carvalho-Filho RJ, Silva IS, Silva AE, Ferraz ML.

Braz J Infect Dis. 2014 Nov-Dec;18(6):625-30. doi: 10.1016/j.bjid.2014.06.004. Epub 2014 Aug 29.

43.

Determining cut-off points for enhanced liver fibrosis panel.

Fernandes FF, de Mello Perez R, Ferraz ML.

J Clin Gastroenterol. 2015 Jan;49(1):91-2. doi: 10.1097/MCG.0000000000000195. No abstract available.

PMID:
25144901
44.

Fatal outcome of infection by dengue 4 in a patient with thrombocytopenic purpura as a comorbid condition in Brazil.

Amâncio FF, Pereira MA, Iani FC, D'anunciação L, de Almeida JL, Soares JA, Ferraz ML, Vale TC, Lambertucci JR, Carneiro M.

Rev Inst Med Trop Sao Paulo. 2014 May-Jun;56(3):267-70.

45.

Do differences exist between chronic hepatitis C genotypes 2 and 3?

Melo IC, Ferraz ML, Perez RM, Emori CT, Uehara SN, de Carvalho-Filho RJ, Silva AE, de Souza e Silva IS.

Rev Soc Bras Med Trop. 2014 Mar-Apr;47(2):143-8.

46.

Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Keppeke GD, Satoh M, Ferraz ML, Chan EK, Andrade LE.

Immunol Res. 2014 Oct;60(1):38-49. doi: 10.1007/s12026-014-8515-2.

PMID:
24845459
47.

Acute pancreatitis associated with boceprevir: a case report.

Bilar JM, Carvalho-Filho RJ, Mota CF, Fucuta Pda S, Ferraz ML.

Braz J Infect Dis. 2014 Jul-Aug;18(4):454-6. doi: 10.1016/j.bjid.2014.03.008. Epub 2014 May 13.

48.

Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.

Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Figueiredo F, Perez RM.

J Clin Gastroenterol. 2015 Mar;49(3):235-41. doi: 10.1097/MCG.0000000000000128.

PMID:
24714186
49.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
50.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005

Supplemental Content

Loading ...
Support Center